&Dgr;P62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer
US6544948B1 · kind B1 · utility
3Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 25, 1997 |
| Grant date | Apr 8, 2003 |
| Priority date | — |
| Expiry date | Nov 25, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A polypeptide derivative of p62 having at least one deletion of at least one amino acid between amino acids 145 to 247 of p62, where the derivative inhibits signals transduced by ras.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.